Integra LifeSciences (IART) Earnings Date, Estimates & Call Transcripts $31.43 -0.10 (-0.32%) (As of 07/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJul. 29Before Market OpensConfirmedActual EPS (May. 6) $0.55 Consensus EPS (May. 6) $0.55 Read Call TranscriptListen to Call Get Integra LifeSciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for IART and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIART Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IART Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Integra LifeSciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.55$0.55$0.550.530 - 0.570Q2 20241$0.74$0.74$0.740.600 - 0.650Q3 20241$0.87$0.87$0.87 Q4 20241$1.00$1.00$1.00 FY 20244$3.16$3.16$3.16 Q1 20251$0.74$0.74$0.74 Q2 20251$0.76$0.76$0.76 Q3 20251$0.98$0.98$0.98 Q4 20251$1.03$1.03$1.03 FY 20254$3.51$3.51$3.51 Q1 20261$0.72$0.72$0.72 IART Earnings Date and InformationIntegra LifeSciences last announced its quarterly earnings data on May 6th, 2024. The life sciences company reported $0.55 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.55. The firm earned $368.90 million during the quarter, compared to the consensus estimate of $361.96 million. Its quarterly revenue was down 3.2% compared to the same quarter last year. Integra LifeSciences has generated $0.50 earnings per share over the last year ($0.50 diluted earnings per share) and currently has a price-to-earnings ratio of 62.9. Earnings for Integra LifeSciences are expected to grow by 7.92% in the coming year, from $3.03 to $3.27 per share. Integra LifeSciences has confirmed that its next quarterly earnings report will be published on Monday, July 29th, 2024. Integra LifeSciences will be holding an earnings conference call on Monday, July 29th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Integra LifeSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/29/2024(Confirmed)------- 5/6/2024Q1 2024$0.55$0.55-$1.14$361.96 million$368.90 million 2/28/2024Q4 2023$0.90$0.89($0.01)$1.53$399.30 million$397.00 million 10/25/2023Q3 2023$0.78$0.76($0.02)$1.28$387.22 million$382.40 million 7/26/2023Q2 2023$0.57$0.71+$0.14$1.37$388.79 million$381.30 million 4/26/2023Q1 2023$0.74$0.74-$1.19$373.21 million$380.85 million 2/22/2023Q4 2022$0.93$0.94+$0.01$1.25$398.57 million$398.00 million Get the Latest News and Ratings for IART and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter. 10/26/2022Q3 2022$0.72$0.86+$0.14$1.12$377.79 million$385.19 million7/27/2022Q2 2022$0.80$0.82+$0.02$1.10$394.54 million$397.82 million4/27/2022Q1 2022$0.68$0.74+$0.06$1.09$362.19 million$376.60 million 2/23/2022Q4 2021$0.83$0.84+$0.01$1.15$403.41 million$405.52 million 11/1/2021Q3 2021$0.72$0.86+$0.14$1.21$384.47 million$386.86 million 7/27/2021Q2 2021$0.66$0.79+$0.13$1.17$376.11 million$389.99 million 4/27/2021Q1 2021$0.57$0.69+$0.12$0.85$349.78 million$360.10 million 2/17/2021Q4 2020$0.73$0.84+$0.11$0.59$387.51 million$388.65 million 10/28/2020Q3 2020$0.57$0.80+$0.23$1.22$368.91 million$370.23 million 8/10/2020Q2 2020$0.10$0.33+$0.23$0.66$252.54 million$258.67 million 5/7/2020Q1 2020$0.63$0.48($0.15)$0.85$353.15 million$354.30 million 2/19/2020Q4 2019$0.67$0.68+$0.01$1.18$397.51 million$395.13 million 10/24/2019Q3 2019$0.65$0.68+$0.03$1.68$376.85 million$379.10 million Integra LifeSciences Earnings - Frequently Asked Questions When is Integra LifeSciences's earnings date? Integra LifeSciences has confirmed that its next quarterly earnings data will be published on Monday, July 29th, 2024. Learn more on IART's earnings history. What guidance has Integra LifeSciences issued on next quarter's earnings? Integra LifeSciences updated its FY24 earnings guidance on Monday, May, 6th. The company provided earnings per share (EPS) guidance of $3.01-3.11 for the period, compared to the consensus earnings per share estimate of $3.19. The company issued revenue guidance of $1.67-1.69 billion, compared to the consensus revenue estimate of $1.62 billion. Did Integra LifeSciences beat their earnings estimates last quarter? In the previous quarter, Integra LifeSciences (NASDAQ:IART) reported $0.55 earnings per share (EPS) to hit the analysts' consensus estimate of $0.55. Learn more on analysts' earnings estimate vs. IART's actual earnings. How can I listen to Integra LifeSciences's earnings conference call? The conference call for Integra LifeSciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Integra LifeSciences's conference call transcript? The conference call transcript for Integra LifeSciences's latest earnings report can be read online. Read Transcript How much revenue does Integra LifeSciences generate each year? Integra LifeSciences (NASDAQ:IART) has a recorded annual revenue of $1.53 billion. How much profit does Integra LifeSciences generate each year? Integra LifeSciences (NASDAQ:IART) has a recorded net income of $67.74 million. IART has generated $0.50 earnings per share over the last four quarters. What is Integra LifeSciences's price-to-earnings ratio? Integra LifeSciences (NASDAQ:IART) has a trailing price-to-earnings ratio of 62.86 and a forward price-to-earnings ratio of 10.37. The price/earnings-to-growth ratio is 1.14. What is Integra LifeSciences's EPS forecast for next year? Integra LifeSciences's earnings are expected to grow from $3.03 per share to $3.27 per share in the next year, which is a 7.92% increase. More Earnings Resources from MarketBeat Related Companies: MDXG Earnings GMED Earnings MASI Earnings ITGR Earnings ATEC Earnings ATRC Earnings SRDX Earnings OFIX Earnings ANGO Earnings ARAY Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (NASDAQ:IART) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
